Induction of Human Immunodeficiency Virus (HIV-1) Envelope Specific Cell-Mediated Immunity by a Non-Homologous Synthetic Peptide Theoretically Designed Peptide
2007

Induction of HIV-1 Specific Cell-Mediated Immunity by a Synthetic Peptide

Sample size: 10 publication 10 minutes Evidence: moderate

Author Information

Author(s): Achour Ammar, Biquard Jean-Michel, Krsmanovic Velibor, M'Bika Jean-Pierre, Ficheux Damien, Sikorska Marianna, Cozzone Alain J.

Primary Institution: Laboratoire des Interférons, Université Paris Descartes, Paris, France

Hypothesis

Can a non-homologous synthetic peptide induce a cellular immune response against HIV-1?

Conclusion

The cA1 peptide can effectively induce a cellular immune response in both immunized rabbits and HIV-infected individuals.

Supporting Evidence

  • The cA1 peptide was recognized by cytotoxic T lymphocytes in HIV-1-infected individuals.
  • Immunized rabbits showed a strong T-cell proliferation response to the cA1 peptide.
  • The cA1 peptide was able to prime CTLs from gp160-immunized individuals.
  • Multiple HLA Class I molecules recognized the cA1 peptide.
  • The study suggests a novel strategy for developing a synthetic AIDS vaccine.

Takeaway

Scientists created a special peptide that helps the body fight HIV by training immune cells to recognize and attack the virus.

Methodology

The study involved synthesizing a peptide and testing its ability to stimulate T-cell responses in immunized rabbits and HIV-infected individuals.

Limitations

The study did not provide detailed HLA typing for all participants, which may affect the interpretation of immune responses.

Participant Demographics

Participants included healthy HIV-1-seronegative individuals and HIV-1-infected individuals with varying CD4+ T cell counts.

Digital Object Identifier (DOI)

10.1371/journal.pone.0001214

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication